Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Leukemia

Free Subscription Articles published in Blood Retrieve available abstracts of 447 articles: HTML format

Single Articles

May 2008
1. CROSS NC
   Hitchhikers' guide to the leukemia genome.
   Blood. 2008;111:4428-9.
   PubMed     Related articles   
   
   
   April 2008
2. KUJAWSKI L , Ouillette P, Erba H, Saddler C, et al
   Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. ELLIS NA , Huo D, Yildiz O, Worrillow LJ, et al
   MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. CROWTHER D , Wild R, Sellick G, Dyer MJ, et al
   Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. AYDIN S , Rossi D, Bergui L, D'Arena G, et al
   CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter's syndrome?
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. TAM CS , O'Brien S, Wierda W, Kantarjian H, et al
   Long term results of the fludarabine, cyclophosphamide & rituximab regimen as initial therapy of chronic lymphocytic leukemia.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. JABBOUR E , Kantarjian H, Jones D, Breeden M, et al
   Characteristics and outcome of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. MARKS DI , Perez WS, He W, Zhang MJ, et al
   Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. JANKOVIC D , Gorello P, Liu T, Ehret S, et al
   Leukemogenic mechanisms and targets of NUP98/HHEX fusion in acute myeloid leukemia (AML).
   Blood. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. BOROWITZ MJ , Devidas M, Hunger SP, Bowman WP, et al
    Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. WIMMER-KLEIKAMP SH , Nievergall E, Gegenbauer K, Adikari S, et al
    Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. HAMADANI M , Awan FT, Devine SM
    The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation.
    Blood. 2008;111:3901-2.
    PubMed     Related articles   
    
    
    March 2008
13. LANGER C , Radmacher MD, Ruppert AS, Whitman SP, et al
    High BAALC expression associates with other molecular prognostic markers, poor outcome and a distinct gene-expression signature in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. SCUTO A , Kirschbaum M, Kowolik C, Kretzner L, et al
    The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. KITADA S , Kress CL, Krajewska M, Jia L, et al
    Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).
    Blood. 2008;111:3211-9.
    PubMed     Related articles    Abstract available
    
    
    
16. SALLMYR A , Fan J, Datta K, Kim KT, et al
    Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.
    Blood. 2008;111:3173-82.
    PubMed     Related articles    Abstract available
    
    
    
17. MONNI R , Haddaoui L, Naba A, Gallais I, et al
    Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia.
    Blood. 2008;111:3163-72.
    PubMed     Related articles    Abstract available
    
    
    
18. CHEN YY , Malik M, Tomkowicz BE, Collman RG, et al
    BCR-ABL1 alters SDF-1{alpha} mediated adhesive responses through the {beta}2 integrin LFA-1 in leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. CHEN J , Petrus M, Bryant BR, Nguyen VP, et al
    Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. JONGEN-LAVRENCIC M , Sun SM, Dijkstra MK, Valk PJ, et al
    MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. FERRAJOLI A , Lee BN, Schlette EJ, O'Brien SM, et al
    Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. MODY R , Li S, Dover DC, Sallan S, et al
    Twenty five year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. PATTEN PE , Buggins AG, Richards J, Wotherspoon A, et al
    CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. GHIA EM , Jain S, Widhopf GF, Rassenti LZ, et al
    Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal-center leukemogenic selection.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. WALTER RB , Boyle KM, Appelbaum FR, Bernstein ID, et al
    Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. WANG ZY , Chen Z
    Acute promyelocytic leukemia: from highly fatal to highly curable.
    Blood. 2008;111:2505-15.
    PubMed     Related articles    Abstract available
    
    
    
27. MEYER LH , Queudeville M, Eckhoff SM, Creutzig U, et al
    Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML.
    Blood. 2008;111:2899-903.
    PubMed     Related articles    Abstract available
    
    
    
28. FITTER S , Dewar AL, Kostakis P, To LB, et al
    Long-term imatinib therapy promotes bone formation in CML patients.
    Blood. 2008;111:2538-47.
    PubMed     Related articles    Abstract available
    
    
    
29. HOEMME C , Peerzada A, Behre G, Wang Y, et al
    Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip.
    Blood. 2008;111:2887-95.
    PubMed     Related articles    Abstract available
    
    
    
30. BACHER U , Haferlach C, Kern W, Haferlach T, et al
    Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients.
    Blood. 2008;111:2527-37.
    PubMed     Related articles    Abstract available
    
    
    February 2008
31. NISHIOKA C , Ikezoe T, Yang J, Miwa A, et al
    Ki11502, a novel multi-targeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. BRENNER H , Gondos A, Pulte D
    Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. SAITOH Y , Yamamoto N, Dewan MZ, Sugimoto H, et al
    Overexpressed NF-{kappa}B inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. HASSANE DC , Guzman ML, Corbett C, Li X, et al
    Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
35. LI FJ , Ding S, Pan J, Shakhmatov MA, et al
    FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. VAN VLIERBERGHE P , van Grotel M, Tchinda J, Lee C, et al
    The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. FRENCH D , Hamilton LH, Mattano LA Jr, Sather HN, et al
    A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. MORICKE A , Reiter A, Zimmermann M, Gadner H, et al
    Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. VYAS P , Crispino J
    Response: JAK mutations in Down syndrome-associated transient myeloproliferative disorder and acute megakaryocytic leukemia.
    Blood. 2008;111:2493.
    PubMed     Related articles   
    
    
    
40. HAMA A , Yagasaki H, Takahashi Y, Matsumoto K, et al
    Response: Mutations of JAK2, JAK3 and GATA1 in acute megakaryoblastic leukemia of Down syndrome.
    Blood. 2008;111:2493-4.
    PubMed     Related articles   
    
    
    
41. FLOTHO C , Coustan-Smith E, Pei D, Cheng C, et al
    Response: Genes associated with response to therapy in childhood acute lymphoblastic leukemia.
    Blood. 2008;111:2487-8.
    PubMed     Related articles   
    
    
    
42. CATCHPOOLE D , Guo D, Jiang H, Biesheuvel C, et al
    Predicting outcome in childhood acute lymphoblastic leukemia using gene expression profiling: Prognostication or protocol selection?
    Blood. 2008;111:2486-7.
    PubMed     Related articles   
    
    
    
43. LUGTHART S , Drunen EV, Norden YV, Hoven AV, et al
    High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. TOMASSON MH , Xiang Z, Walgren R, Zhao Y, et al
    Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. LARSON RA , Druker BJ, Guilhot FA, O'Brien SG, et al
    Imatinib pharmacokinetics and its correlation with response and safety in chronic phase chronic myeloid leukemia: a subanalysis of the IRIS study.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. LORIAUX MM , Levine RL, Tyner JW, Frohling S, et al
    High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. GIANFALDONI G , Mannelli F, Bencini S, Leoni F, et al
    Peripheral blood blast clearance during induction therapy in acute myeloid leukemia.
    Blood. 2008;111:1746-7.
    PubMed     Related articles   
    
    
    
48. VAN WAGENINGEN S , Breems-de Ridder MC, Nigten J, Nikoloski G, et al
    Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha.
    Blood. 2008;111:1634-43.
    PubMed     Related articles    Abstract available
    
    
    
49. SELLICK GS , Wade R, Richards S, Oscier DG, et al
    Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.
    Blood. 2008;111:1625-33.
    PubMed     Related articles    Abstract available
    
    
    
50. DIERMAYR S , Himmelreich H, Durovic B, Mathys-Schneeberger A, et al
    NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities.
    Blood. 2008;111:1428-36.
    PubMed     Related articles    Abstract available
    
    
    
51. CHENG JC , Kinjo K, Judelson DR, Chang J, et al
    CREB is a critical regulator of normal hematopoiesis and leukemogenesis.
    Blood. 2008;111:1182-92.
    PubMed     Related articles    Abstract available
    
    
    
52. FORESTIER E , Izraeli S, Beverloo B, Haas O, et al
    Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
    Blood. 2008;111:1575-83.
    PubMed     Related articles    Abstract available
    
    
    
53. GARCIA-MANERO G , Yang H, Bueso-Ramos C, Ferrajoli A, et al
    Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.
    Blood. 2008;111:1060-6.
    PubMed     Related articles    Abstract available
    
    
    
54. GONDEK LP , Tiu R, O'Keefe CL, Sekeres MA, et al
    Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML.
    Blood. 2008;111:1534-42.
    PubMed     Related articles    Abstract available
    
    
    
55. SYRJALA KL , Kurland BF, Abrams JR, Sanders JE, et al
    Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.
    Blood. 2008;111:989-96.
    PubMed     Related articles    Abstract available
    
    
    January 2008
56. WU J , Meng F, Lu H, Kong L, et al
    Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib resistant chronic myelogenous leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
57. LANEMO MYHRINDER A , Hellqvist E, Sidorova E, Soderberg A, et al
    A new perspective: molecular motifs on oxidized-LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
58. MOARBESS G , El-Hajj H, Kfoury Y, El-Sabban ME, et al
    EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase dependent apoptosis in T cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. HALLEK M , Cheson BD, Catovsky D, Caligaris-Cappio F, et al
    Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
60. HASEMANN MS , Damgaard I, Schuster MB, Theilgaard-Monch K, et al
    Mutation of C/EBP{alpha} predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
61. KOIKE K , Matsuda K
    Evaluation of relationship between the genetic abnormalities and disease phenotype is required in juvenile myelomonocytic leukemia.
    Blood. 2008;111:967-8.
    PubMed     Related articles       Free Full Text
    
    
    
62. FLOTHO C , Kratz CP, Bergstrasser E, Hasle H, et al
    Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations.
    Blood. 2008;111:966-7.
    PubMed     Related articles       Free Full Text
    
    
    
63. DE TOTERO D , Meazza R, Capaia M, Fabbi M, et al
    The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.
    Blood. 2008;111:517-24.
    PubMed     Related articles    Abstract available
    
    
    
64. STAGNI V , di Bari MG, Cursi S, Condo I, et al
    ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.
    Blood. 2008;111:829-37.
    PubMed     Related articles    Abstract available
    
    
    
65. EIRING AM , Neviani P, Santhanam R, Oaks JJ, et al
    Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.
    Blood. 2008;111:816-28.
    PubMed     Related articles    Abstract available
    
    
    
66. KAWAMATA N , Ogawa S, Zimmermann M, Kato M, et al
    Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.
    Blood. 2008;111:776-84.
    PubMed     Related articles    Abstract available
    
    
    
67. DE LA SERNA J , Montesinos P, Vellenga E, Rayon C, et al
    Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
68. HUSSAIN SR , Lucas DM, Johnson AJ, Lin TS, et al
    Flavopiridol causes early mitochondrial damage in chronic lymphocytic leukemia cells with impaired oxygen consumption and mobilization of intracellular calcium.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
69. GARZON R , Volinia S, Liu CG, Fernandez-Cymering C, et al
    MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
70. DUHAMEL M , Arrouss I, Merle-Beral H, Rebollo A, et al
    The aiolos transcription factor is up-regulated in chronic lymphocytic leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
71. KLUSMANN JH , Creutzig U, Zimmermann M, Dworzak M, et al
    Treatment and prognostic impact of transient leukemia in neonates with Down's syndrome.
    Blood. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
72. GAUSDAL G , Gjertsen BT, McCormack E, Van Damme P, et al
    Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
73. DAVIES SM , Borowitz MJ, Rosner GL, Ritz K, et al
    Pharmacogenetics of minimal residual disease response in children with Acute Lymphoblastic Leukemia (ALL): a report from the Children's Oncology Group.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
74. BAN K , Gao Y, Amin HM, Howard A, et al
    BCR-ABL1 mediates upregulation of Fyn in chronic myelogenous leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
75. WANG SF , Aoki M, Nakashima Y, Shinozuka Y, et al
    Development of Notch-dependent T-cell leukemia by deregulated Rap1 signaling.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
76. BALGOBIND BV , Van Vlierberghe P, van den Ouweland AM, Beverloo HB, et al
    Leukemia associated NF1 inactivation in pediatric T-ALL and AML patients lacking evidence for neurofibromatosis.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
77. DEENIK W , van der Holt B, Verhoef GE, Smit WM, et al
    Dose finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
78. ROSSI D , Rasi S, Capello D, Gaidano G, et al
    Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemia.
    Blood. 2008;111:466-8.
    PubMed     Related articles   
    
    
    
79. RELLING MV , Evans WE, Pui CH
    Continue to study childhood ALL.
    Blood. 2008;111:468-9.
    PubMed     Related articles   
    
    
    
80. RUSSELL LJ , Akasaka T, Majid A, Sugimoto KJ, et al
    t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).
    Blood. 2008;111:387-91.
    PubMed     Related articles    Abstract available
    
    
    
81. EGUCHI-ISHIMAE M , Eguchi M, Kempski H, Greaves M, et al
    NOTCH1 mutation can be an early, prenatal genetic event in T-ALL.
    Blood. 2008;111:376-8.
    PubMed     Related articles    Abstract available
    
    
    
82. REDONDO-MUNOZ J , Jose Terol M, Garcia-Marco JA, Garcia-Pardo A, et al
    Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration.
    Blood. 2008;111:383-6.
    PubMed     Related articles    Abstract available
    
    
    
83. YANG G , Huang SC, Wu JY, Benz EJ Jr, et al
    Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation.
    Blood. 2008;111:392-401.
    PubMed     Related articles    Abstract available
    
    
    December 2007
84. XIANG Z , Zhao Y, Mitaksov V, Fremont DH, et al
    Identification of somatic JAK1 mutations in patients with acute myeloid leukemia.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. RAPONI M , Lancet JE, Fan H, Dossey L, et al
    A two-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. AGRAWAL SG , Liu FT, Wiseman C, Shirali S, et al
    Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. HUANG XF , Luo SK, Xu J, Li J, et al
    Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. COPLAND M , Pellicano F, Richmond L, Allan EK, et al
    BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergises with tyrosine kinase inhibitors.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. PULLARKAT VA , Slovak ML, Kopecky KJ, Forman SJ, et al
    Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group study SWOG-9400.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
90. VON STACKELBERG A , Hartmann R, Buhrer C, Fengler R, et al
    High-dose as compared with intermediate-dose methotrexate in children with a first relapse of acute lymphoblastic leukemia.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. HOLTICK U , Marshall SR, O'Brien SG, Collin MP, et al
    Potent graft-versus-leukemia effect in BCR/ABL negative chronic myelogenous leukemia.
    Blood. 2007;110:4622-3.
    PubMed     Related articles   
    
    
    
92. STEVENS JM , Syndercombe-Court D, Oakervee HE, McCloskey D, et al
    Development of original donor cell leukemia after successful engraftment from a second donor.
    Blood. 2007;110:4621-2.
    PubMed     Related articles   
    
    
    
93. CORNELISSEN JJ , van Putten W, Lowenberg B
    Response: Allogeneic hematopoetic stem-cell transplantation in acute myeloid leukemia.
    Blood. 2007;110:4619-20.
    PubMed     Related articles   
    
    
    
94. ANTONIOLI E , Guglielmelli P, Poli G, Santini V, et al
    Polycythemia vera following autologous transplantation for AML: insights on the kinetics of JAK2V617F clonal dominance.
    Blood. 2007;110:4620-1.
    PubMed     Related articles   
    
    
    
95. AILAWADHI S , Padmanabhan S
    HLA-identical sibling stem-cell transplantation in first-remission AML.
    Blood. 2007;110:4619.
    PubMed     Related articles   
    
    
    
96. LITTLEWOOD T , Malladi R, Peniket A
    No more transplantation in CML?
    Blood. 2007;110:4618.
    PubMed     Related articles   
    
    
    
97. LIU S , Liu Z, Xie Z, Pang J, et al
    Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-{kappa}B-dependent DNA methyltransferase activity in acute myeloid leukemia.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. PONCET D , Belleville A, T'kint de Roodenbeke C, Roborel de Climens A, et al
    Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B chronic lymphocytic leukemia.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. RITCHIE DS , McBean M, Westerman DA, Kovalenko S, et al
    Complete molecular response of e6a2 BCR-ABL positive acute myeloid leukemia to Imatinib then Dasatinib.
    Blood. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. LE TORIELLEC E , Despouy G, Pierron G, Gaye N, et al
     Haplo-insufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. KONIG H , Holyoake TL, Bhatia R
     Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
102. DEL GAIZO MOORE V , Schlis KD, Sallan SE, Armstrong SA, et al
     BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. WANDT H , Schakel U, Kroschinsky F, Prange-Krex G, et al
     Multilineage dysplasia according to the World Health Organisation (WHO) classification in acute myeloid leukemia (AML) has no correlation with age and no independent prognostic relevance as analysed in 1766 patients.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
104. DOS SANTOS C , Demur C, Bardet V, Prade-Houdellier N, et al
     A critical role for Lyn in Acute Myeloid Leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
105. YING J , Li H, Chen YW, Srivastava G, et al
     WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor.
     Blood. 2007;110:4130-1.
     PubMed     Related articles   
     
     
     
106. WHITE DL , Saunders VA, Dang P, Engler J, et al
     Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity.
     Blood. 2007;110:4064-72.
     PubMed     Related articles    Abstract available
     
     
     
107. RIX U , Hantschel O, Durnberger G, Remsing Rix LL, et al
     Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets.
     Blood. 2007;110:4055-63.
     PubMed     Related articles    Abstract available
     
     
     
108. BAROSI G , Bergamaschi G, Marchetti M, Vannucchi AM, et al
     JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.
     Blood. 2007;110:4030-6.
     PubMed     Related articles    Abstract available
     
     
     
109. DEAGLIO S , Vaisitti T, Aydin S, Bergui L, et al
     CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
     Blood. 2007;110:4012-21.
     PubMed     Related articles    Abstract available
     
     
     November 2007
110. DEARDEN C , Wade R, Else M, Richards S, et al
     The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia - a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
111. KANTARJIAN H , Schiffer C, Jones D, Cortes J, et al
     Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. OKI Y , Jelinek J, Shen L, Kantarjian HM, et al
     Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. CHEN L , Huynh L, Apgar J, Tang L, et al
     ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. GOLDSTONE AH , Richards SM, Lazarus HM, Tallman MS, et al
     In adults with standard-risk acute lymphoblastic leukemia (ALL) the greatest benefit is achieved from a matched sibling allogeneic transplant in first complete remission (CR) and an autologous transplant is less effective than conventional consolidation/
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. LE COUTRE P , Ottmann OG, Giles F, Kim DW, et al
     Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated phase chronic myelogenous leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
116. ROOS G , Krober A, Grabowski P, Kienle D, et al
     Short telomeres are associated with genetic complexity, high risk genomic aberrations, and short survival in chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. ZHENG H , Matte-Martone C, Li H, Anderson BE, et al
     Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. PAGEL JM , Hedin N, Drouet L, Wood BL, et al
     Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. SEIBEL NL , Steinherz PG, Sather HN, Nachman JB, et al
     Early post-induction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. PATHAN NI , Chu P, Hariharan K, Cheney C, et al
     Mediation of apoptosis by and anti-tumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. TYNER JW , Walters DK, Willis SG, Luttropp M, et al
     RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
122. MAYERHOFER M , Gleixner KV, Mayerhofer J, Hoermann G, et al
     Targeting of heat shock protein 32 (Hsp32) / heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. GOTHERT JR , Brake RL, Smeets M, Duhrsen U, et al
     NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis.
     Blood. 2007;110:3753-62.
     PubMed     Related articles    Abstract available
     
     
     
124. KOSCHMIEDER S , D'Alo F, Radomska H, Schoneich C, et al
     CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.
     Blood. 2007;110:3695-705.
     PubMed     Related articles    Abstract available
     
     
     
125. COIFFIER B , Lepretre S, Moller Pedersen L, Gadeberg O, et al
     Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia. A phase I-II study.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
126. LANGE BJ , Smith FO, Feusner J, Barnard D, et al
     Outcomes in CCG-2961, a Children's Oncology Group phase 3 trial for untreated pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
127. ARCHAMBEAULT S , Flores NJ, Yoshimi A, Kratz CP, et al
     Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
128. GLASOW A , Barrett A, Petrie K, Gupta R, et al
     DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
129. YANG J , Epling-Burnette PK, Painter JS, Zou J, et al
     Antigen activation and impaired Fas-induced DISC formation in LGL leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
130. VISCO C , Ruggeri M, Evangelista ML, Stasi R, et al
     Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
131. ADES L , Sanz MA, Chevret S, Montesinos P, et al
     Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
132. GELETU M , Balkhi MY, Peer Zada AA, Christopeit M, et al
     Target proteins of C/EBPalphap30 in AML: C/EBPalphap30 enhances sumoylation of C/EBPalphap42 via up-regulation of Ubc9.
     Blood. 2007;110:3301-9.
     PubMed     Related articles    Abstract available
     
     
     October 2007
133. SCHMITT M , Schmitt A, Rojewski MT, Chen J, et al
     RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma elicits immunological and clinical responses.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
134. SADDLER C , Ouillette P, Kujawski L, Shangary S, et al
     Comprehensive biomarker and genomic analysis identifies P53 status as the major determinant of response to MDM2 inhibitors in chronic lymphcytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
135. KIM HG , Kojima K, Swindle CS, Cotta CV, et al
     FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
136. MURRAY F , Darzentas N, Hadzidimitriou A, Tobin G, et al
     Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
137. MAJID A , Tsoulakis O, Walewska R, Gesk S, et al
     BCL2 expression in chronic lymphocytic leukemia (CLL): lack of association with the BCL2 -938A>C promoter single nucleotide polymorphism (SNP).
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
138. FOX E , Razzouk BI, Widemann BC, Xiao S, et al
     Phase I trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia including acute promyelocytic leukemia or lymphoma A collaborative study of The Pediatric Oncology Branch, National Cancer
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. GATTEI V , Bulian P, Del Principe MI, Zucchetto A, et al
     Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
140. GALE RE , Green C, Allen C, Mead AJ, et al
     The impact of FLT3 internal tandem duplication mutant level, number, size and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
141. WHITMAN SP , Ruppert AS, Radmacher MD, Mrozek K, et al
     FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. PARK S , Grabar S, Kelaidi C, Beyne-Rauzy O, et al
     Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. DE MELO VA , Milojkovic D, Khorashad JS, Marin D, et al
     Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia.
     Blood. 2007;110:3086-7.
     PubMed     Related articles   
     
     
     
144. LICHTMAN MA
     Chronic megakaryocytic leukemia, misnamed chronic idiopathic myelofibrosis, has neoplastic not hyperplastic megakaryocytopoiesis.
     Blood. 2007;110:3085-6.
     PubMed     Related articles   
     
     
     
145. SCHEPERS H , van Gosliga D, Wierenga AT, Eggen BJ, et al
     STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.
     Blood. 2007;110:2880-8.
     PubMed     Related articles    Abstract available
     
     
     
146. HOCHHAUS A , Druker B, Sawyers C, Guilhot F, et al
     Favorable long-term follow-up results over six years for response, survival and safety with imatinib mesylate therapy in chronic phase chronic myeloid leukemia post failure of interferon-alpha treatment.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. LIANG Y , Liu C, Djeu JY, Zhong B, et al
     {beta}2 integrins separates graft-versus-host disease and graft-versus-leukemia effect.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. LONGO PG , Laurenti L, Gobessi S, Sica S, et al
     The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B-cells.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. SORROR ML , Storer BE, Maloney DG, Sandmaier BM, et al
     Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. DE LAVALLADE H , Khorashad JS, Davis HP, Milojkovic D, et al
     Interferon-{alpha} or homoharringtonine as salvage treatment for chronic myeloid leukemia patients who acquire the T315I BCR-ABL mutation.
     Blood. 2007;110:2779-80.
     PubMed     Related articles   
     
     
     
151. BUNTING KD , Xie XY, Warshawsky I, Hsi ED, et al
     Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD.
     Blood. 2007;110:2775-6.
     PubMed     Related articles   
     
     
     
152. STAM RW , Schneider P, de Lorenzo P, Valsecchi MG, et al
     Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia.
     Blood. 2007;110:2774-5.
     PubMed     Related articles   
     
     
     
153. ELLIOTT MA , Litzow MR, Letendre LL, Wolf RC, et al
     Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
154. BERGERON J , Clappier E, Radford I, Buzyn A, et al
     Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs.
     Blood. 2007;110:2324-30.
     PubMed     Related articles    Abstract available
     
     
     
155. KAHL C , Storer BE, Sandmaier BM, Mielcarek M, et al
     Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
     Blood. 2007;110:2744-8.
     PubMed     Related articles    Abstract available
     
     
     
156. CUI JW , Li YJ, Sarkar A, Brown J, et al
     Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert Epo-induced differentiation to proliferation.
     Blood. 2007;110:2631-40.
     PubMed     Related articles    Abstract available
     
     
     
157. SCHEICH F , Duyster J, Peschel C, Bernhard H, et al
     The immunogenicity of Bcr-Abl expressing dendritic cells is dependent on the Bcr-Abl kinase activity and dominated by Bcr-Abl regulated antigens.
     Blood. 2007;110:2556-60.
     PubMed     Related articles    Abstract available
     
     
     
158. FASSEU M , Aplan PD, Chopin M, Boissel N, et al
     p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.
     Blood. 2007;110:2610-9.
     PubMed     Related articles    Abstract available
     
     
     
159. ZHAO X , Lapalombella R, Joshi T, Cheney C, et al
     Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.
     Blood. 2007;110:2569-77.
     PubMed     Related articles    Abstract available
     
     
     September 2007
160. SAUVAGEAU M , Miller M, Lemieux S, Lessard J, et al
     Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type-specific cancer genes in leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
161. DU X , Nagata S, Ise T, Stetler-Stevenson M, et al
     FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia and B-cell non-Hodgkin's lymphoma as a target of immunotoxins.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
162. BARLOGIE B , Tricot G, Haessler J, van Rhee F, et al
     Cytogenetically defined myelodysplasia after melphalan-based autotranplants for multiple myeloma linked to poor hematopoietic stem cell mobilization: the Arkansas experience in more than 3000 patients treated since 1989.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
163. HIYOSHI M , Suzu S, Yoshidomi Y, Hassan R, et al
     Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
164. HERLING M , Patel KA, Teitell MA, Konopleva M, et al
     High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
165. BESSETTE K , Lang M, Fava RA, Grundy M, et al
     A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
166. OLAVARRIA E , Siddique S, Griffiths MJ, Avery S, et al
     Post-transplant imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced intensity allografts for chronic myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
167. TAMBURINI J , Chapuis N, Bardet V, Park S, et al
     mTORC1 inhibition activates PI3K/Akt by up-regulating IGF-1R signaling in acute myeloid leukemia: rational for therapeutic inhibition of both pathways.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
168. REZVANI K , Yong AS, Mielke S, Savani BN, et al
     Leukemia-associated antigen specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
169. PINE SR , Guo Q, Yin C, Jayabose S, et al
     Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome.
     Blood. 2007;110:2128-31.
     PubMed     Related articles    Abstract available
     
     
     
170. KARP JE , Ricklis RM, Balakrishnan K, Briel J, et al
     A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
     Blood. 2007;110:1762-9.
     PubMed     Related articles    Abstract available
     
     
     
171. CHENG J , Kydd AR, Nakase K, Noonan KM, et al
     Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein.
     Blood. 2007;110:2110-20.
     PubMed     Related articles    Abstract available
     
     
     
172. KORMOCZI GF , Dauber EM, Haas OA, Legler TJ, et al
     Mosaicism due to myeloid lineage restricted loss of heterozygosity as cause of spontaneous Rh phenotype splitting.
     Blood. 2007;110:2148-57.
     PubMed     Related articles    Abstract available
     
     
     
173. RAZ T , Nardi V, Azam M, Cortes J, et al
     Farnesyl transferase inhibitor resistance probed by target mutagenesis.
     Blood. 2007;110:2102-9.
     PubMed     Related articles    Abstract available
     
     
     
174. SORROR ML , Giralt S, Sandmaier BM, De Lima M, et al
     Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
175. RAWAT VP , Thoene S, Naidu VM, Arseni N, et al
     Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. DULUC D , Delneste Y, Tan F, Moles MP, et al
     Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated-macrophage-like cells.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
177. ZEISER R , Youssef S, Baker J, Kambham N, et al
     Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
178. GUZMAN ML , Rossi RM, Neelakantan S, Li X, et al
     An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
179. CORTES J , Jabbour E, Kantarjian H, Yin CC, et al
     Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
180. GUZMAN ML , Li X, Corbett CA, Rossi RM, et al
     Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
181. CHAMBERLAIN MC , Glantz MJ
     Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
     Blood. 2007;110:1698.
     PubMed     Related articles   
     
     
     
182. BLASDEL C , Egorin MJ, Lagattuta TF, Druker BJ, et al
     Therapeutic drug monitoring in CML patients on imatinib.
     Blood. 2007;110:1699-701.
     PubMed     Related articles   
     
     
     
183. LINK DC , Kunter G, Kasai Y, Zhao Y, et al
     Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
     Blood. 2007;110:1648-55.
     PubMed     Related articles    Abstract available
     
     
     
184. GANAPATHI KA , Austin KM, Lee CS, Dias A, et al
     The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA.
     Blood. 2007;110:1458-65.
     PubMed     Related articles    Abstract available
     
     
     August 2007
185. LIU Q , Zhao X, Frissora F, Ma Y, et al
     FTY720 demonstrates promising pre-clinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
186. LOPES JV , Pacheco JM, Dingli D
     Acquired hematopoietic stem cell disorders and mammalian size.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
187. HAGEDORN N , Acquaviva C, Fronkova E, von Stackelberg A, et al
     Sub-microscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of 'isolated' and its possible clinical implications.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
188. KANTARJIAN HM , Giles F, Gattermann N, Bhalla K, et al
     Nilotinib (formerly AMN107), a highly selective Bcr-Abl tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
189. CATALANO A , Dawson MA, Somana K, Opat S, et al
     The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
190. KLION AD , Robyn J, Maric I, Fu W, et al
     Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
191. SCHEPERS H , Wierenga AT, van Gosliga D, Eggen BJ, et al
     Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis.
     Blood. 2007;110:1317-25.
     PubMed     Related articles    Abstract available
     
     
     
192. SELLICK GS , Goldin LR, Wild RW, Slager SL, et al
     A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
193. DAMLE RN , Temburni S, Calissano C, Yancopoulos S, et al
     CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
194. WIDHOPF II GF , Goldberg CJ, Toy TL, Rassenti LZ, et al
     Non-stochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
195. ATALLAH E , Cortes J, O'brien S, Pierce S, et al
     Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
196. CHAN G , Pilichowska M
     Complete remission in a patient with acute myelogenous leukemia treated with erlotinib for non small-cell lung cancer.
     Blood. 2007;110:1079-80.
     PubMed     Related articles   
     
     
     
197. NORTON A , Fisher C, Liu H, Wen Q, et al
     Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
     Blood. 2007;110:1077-9.
     PubMed     Related articles   
     
     
     
198. WOUTERS BJ , Alberich Jorda M, Keeshan K, Louwers I, et al
     Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
199. GIAGOUNIDIS AA
     Decitabine dosage in myelodysplastic syndromes.
     Blood. 2007;110:1082-3.
     PubMed     Related articles   
     
     
     
200. CHANG JS , Santhanam R, Trotta R, Neviani P, et al
     High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.
     Blood. 2007;110:994-1003.
     PubMed     Related articles    Abstract available
     
     
     
201. SARGIN B , Choudhary C, Crosetto N, Schmidt MH, et al
     Flt3-dependent transformation by inactivating c-Cbl mutations in AML.
     Blood. 2007;110:1004-12.
     PubMed     Related articles    Abstract available
     
     
     
202. BROWN P , McIntyre E, Rau R, Meshinchi S, et al
     The incidence and clinical significance of nucleophosmin mutations in childhood AML.
     Blood. 2007;110:979-85.
     PubMed     Related articles    Abstract available
     
     
     
203. TAMBURINI J , Elie C, Bardet V, Chapuis N, et al
     Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients.
     Blood. 2007;110:1025-8.
     PubMed     Related articles    Abstract available
     
     
     
204. KORDASTI SY , Ingram W, Hayden J, Darling D, et al
     CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).
     Blood. 2007;110:847-50.
     PubMed     Related articles    Abstract available
     
     
     
205. KAWASE T , Akatsuka Y, Torikai H, Morishima S, et al
     Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen.
     Blood. 2007;110:1055-63.
     PubMed     Related articles    Abstract available
     
     
     July 2007
206. SUNG L , Lange BJ, Gerbing RB, Alonzo TA, et al
     Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
207. KEBRIAEI P , Detry MA, Giralt S, Carrasco-Yalan A, et al
     Long-term follow-up of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning for patients with chronic myeloid leukemia.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
208. BURKLE A , Niedermeier M, Schmitt-Graff A, Wierda WG, et al
     Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B cell chronic lymphocytic leukemia.
     Blood. 2007;.